Rac1b interfered with Rac1 activation by PDGF, led to a reduction in membrane-bound Rac1, and promoted an increase in Rho activity which finally resulted in tumour-linked alterations in cell morphology and motility [31]. The gene discussed is RAC1; the disease is neoplasm.